Skip to main content

Table 4 Characteristic of patients with elevated level of biomarkers (Troponin-T or CK-MB)

From: Cardiac evaluation in adults with dengue virus infection by serial echocardiography

Demographic

Clinical presentation

Echocardiography

No

Age (y)

Sex

Symptom duration (days)

Classification

Cardiac manifestation

CK-MB level (ng/mL)

Troponin-T (pg/mL)

LVEF

Pericar-dialeffusion

1

2

3

4

1

2

3

4

1

2

3

4

 

1

 < 20

Male

3

DHF

None

323

2.88

–

 < 1.0

 < 50

 < 50

–

 < 50

64

73

–

62

No

2

26–30

Male

4

DHF

Shock

15.8

4.52

2.89

2.58

 < 50

 < 50

 < 50

 < 50

62

65

63

64

No

3

26–30

Male

6

DHF

None

1.01

1.0

–

1.4

 < 50

50–100

–

 < 50

62

71

–

78

No

4

26–30

Male

2

DHF/DSS

Heart failure, shock

1.85

19

19

3.8

 < 50

 < 50

 < 50

 < 50

61

80

80

74

Yes

5

36–40

Male

3

DHF

Myocarditis

2.33

18.2

–

14.9

 < 50

1344

–

962

69

50

–

69

No

6

31–35

Female

3

DSS

Myocarditis, shock

7.55

9.78

5.73

1.35

392

1210

1456

139

57

45

50

76

Yes

  1. CK-MB creatine kinase–myocardial band, DHF dengue haemorrhagic fever, DSS dengue shock syndrome, LVEF left ventricular ejection fraction. 1, the day of admission; 2, the day of defervescence; 3, the first day of hypotension; 4, 2 week follow up day